Johnson Matthey | JMAT
Stock Price
1,493.00
Daily Change
-16.00 -1.06%
Monthly
-2.42%
Yearly
-6.13%
Q4 Forecast
1,528.34


Peers Price Chg Day Year Date
Covestro 57.32 -0.18 -0.31% 17.22% Nov/27
Air Liquide 156.98 -1.98 -1.25% -9.67% Nov/26
Arkema 74.05 -1.70 -2.24% -20.14% Nov/26
Akzo Nobel 55.02 -1.18 -2.10% -21.04% Nov/26
BASF 42.30 -0.71 -1.65% -2.07% Nov/26
Bayer 18.90 -1.03 -5.19% -40.32% Nov/26
Croda International 3,526.00 -39.00 -1.09% -22.20% Nov/26
Givaudan 3,883.00 -18.00 -0.46% 18.93% Nov/26
Johnson Matthey 1,493.00 -16.00 -1.06% -6.13% Nov/26
Linde 434.00 1.40 0.32% 15.46% Nov/26
Lonza 531.00 4.40 0.84% 54.00% Nov/26
Renewi 560.00 -19.00 -3.28% -8.35% Nov/26
Sika AG 228.60 -2.60 -1.12% -2.72% Nov/26
Solvay 31.13 0.52 1.70% -69.91% Nov/26
Umicore 10.29 -0.31 -2.92% -57.02% Nov/26

Indexes Price Day Year Date
EU600 506 0 0% 10.69% Nov/27

Johnson Matthey traded at 1,493.00 this Tuesday November 26th, decreasing 16.00 or 1.06 percent since the previous trading session. Looking back, over the last four weeks, Johnson Matthey lost 2.42 percent. Over the last 12 months, its price fell by 6.13 percent. Looking ahead, we forecast Johnson Matthey to be priced at 1,528.34 by the end of this quarter and at 1,485.20 in one year, according to Trading Economics global macro models projections and analysts expectations.

Johnson Matthey Plc is a provider of catalysts and catalyst systems to reduce emissions from vehicles and industry. The Company serves customers in global automotive, chemicals, pharmaceuticals and other industrial markets. The Company delivers its solutions through four global sectors: clean air, efficient natural resources, health and new markets. The clean air segment provides catalysts and technologies that abate emissions. The efficient natural resources segment offers products and processes that conserve and recycle scarce resources using less energy and fewer raw materials to chemicals, energy, transport and healthcare sectors. Health segment provides capabilities in complex chemistry, manufacturing and scale up to create active pharmaceutical ingredients and other solutions for niche areas. Its new market segment is engaged in applying its science into emerging opportunities, such as battery materials and fuel cells in the healthcare, transport, energy and chemicals segment.